Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Business Officer
-
Stock Symbol
-
CCCC on Nasdaq
There are no Buy or Sell transactions made by Scott N. Boyle since 10/5/2023
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
53.9K |
$343K |
$6.36 |
Sep 16, 2024 |
Direct |
|
|
| Performance Restricted Stock Units |
14.3K |
$90.6K |
$6.36 |
Sep 16, 2024 |
Direct |
Common Stock |
|
| Stock Option (Right to Buy) |
115K |
|
|
Mar 7, 2024 |
Direct |
Common Stock |
|
Transactions reported by Scott N. Boyle for C4 Therapeutics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.